Primary central nervous system lymphoma: A clinicopathological study of 28 cases

Hematological Oncology

Volumn 18, Issue 1, 2000, Pages 21-32

  Pels, H ^a   Deckert Schluter M ^a   Glasmacher, A ^a   Kleinschmidt, R ^a   Oehring, R ^a   Fischer, H P ^a   Bode, U ^a   Schlegel, U ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

CNS; Lymphoma; Neurotoxicity; Staging; Therapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COGNITION DISORDERS; COMBINED MODALITY THERAPY; CYTARABINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENTRICULAR; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; SPINAL CORD NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034118603     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(200003)18:1<21::AID-HON649>3.0.CO;2-U     Document Type: Article

References (33)

1. Eby NL, Grufferman S, Flannelly CM, Schold Jr SC, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988; 62: 2461-2465.
2. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993; 119: 1093-1104.
3. Corboy JR, Garl PJ, Kleinschmidt DeMasters BK. Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology 1998; 50: 335-340.
4. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68: 835-853.
5. Hutschenreuther M, Wildemann B, Schackert G, Herrmann R, Hacke W. Primary non-Hodgkin's lymphomas of the central nervous system. Nervenarzt 1991; 62: 69-79.
6. Jellinger KA, Paulus W. Primary central nervous system lymphomas - new pathological developments. J Neurooncol 1995; 24: 33-36.
7. Lachance DH, O'Neill BP, Macdonald DR, et al. Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology 1991; 41: 95-100.
8. Jellinger KA, Paulus W. Primary central nervous system lymphomas - an update. J Cancer Res Clin Oncol 1992; 119: 7-27.
9. Sarazin M, Ameri A, Monjour A, Nibio A, Poisson M, Delattre JY. Primary central nervous system lymphoma: treatment with chemotherapy and radiotherapy. Eur J Cancer 1995; 31a: 2003-2007.
10. Jellinger K, Radaskiewicz TH, Slowik F. Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol Suppl Berl 1975; (Suppl 6): 95-102.
11. Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 1984; 60: 94-103.
12. Bogdahn U, Bogdahn S, Mertens HG, et al. Primary non-Hodgkin's lymphomas of the CNS. Acta Neural Scand 1986; 73: 602-614.
13. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 1994; 74: 1383-1397.
14. Blay JY, Conroy T, Chevreau C, et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998; 16: 864-871.
15. Braus DF, Schwechheimer K, Muller Hermelink HK, Schwarzkopf G, Volk B, Mundinger F. Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study. J Neural 1992; 239: 117-124.
16. O'Neill BP, Illig JJ. Primary central nervous system lymphoma. Mayo Clin Proc 1989; 64: 1005-1020.
17. Socie G, Piprot Chauffat C, Schlienger M, et al. Primary lymphoma of the central nervous system. An unresolved therapeutic problem. Cancer 1990; 65: 322-326.
18. O'Neill BP, Dinapoli RP, Kurtin PJ, Habermann TM. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neurooncol 1995; 25: 67-71.
19. Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989; 63: 939-947.
20. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635-643.
21. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radial Oncol Biol Phys 1992; 23: 9-17.
22. Bessell EM, Graus F, Punt JA, et al. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol 1996; 14: 945-954.
23. Chamberlain MC, Levin VA. Primary central nervous system lymphoma: a role for adjuvant chemotherapy. J Neurooncol 1992; 14: 271-275.
24. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994; 81: 188-195.
25. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16: 859-863.
26. Cher L, Glass J, Harsh GR, Hochberg FH. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 1996; 46: 1757-1759.
27. Freilich RJ, Delattre JY, Monjour A, DeAngelis LM. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996; 46: 435-439.
28. Neuwelt EA, Goldman DL, Dahlborg SA, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991; 9: 1580-1590.
29. Sandor V, Stark-Vanes V, Pearson D, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998; 16: 3000-3006.
30. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
31. Reiter A, Schrappe M, Yakisan E, et al. (NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL). Klin Padiatr 1994; 206: 242-252.
32. Alderson L, Fetell MR, Sisti M, Hochberg F, Cohen M, Louis DN. Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry 1996; 60: 102-105.
33. Lien HH, Blomlie V, Saeter G, Solheim O, Fossa SD. Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate. Radiology 1991; 179: 547-550.